Last reviewed · How we verify
NCT05423470
Effect of Intermittent Hypoxia on Ischemia-reperfusion Injury in Healthy Individuals
NA trial testing Intermittent hypoxia in Intermittent Hypoxia in 41 participants. Completed in 1 July 2022.
30 December 2021
Quick facts
| Lead sponsor | University of Texas at Austin |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 41 |
| Start date | 30 May 2019 |
| Primary completion | 30 December 2021 |
| Estimated completion | 1 July 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Intermittent hypoxia
- Intermittent normoxia
Conditions studied
- Intermittent Hypoxia — all drugs for Intermittent Hypoxia →
Sponsor
University of Texas at Austin
Who can join
Adults 18 to 80, any sex, with Intermittent Hypoxia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the present study is to determine whether intermittent hypoxia protects against ischemia-reperfusion injury in young and older healthy individuals. The investigators hypothesize that intermittent hypoxia will attenuate the reduction in flow-mediated dilation following ischemia-reperfusion injury.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05423470
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intermittent hypoxia
Trials testing the same drug.
- NCT06714435 — Effect of Intermittent Hypoxia on Ventilatory Endurance in Healthy Volunteers · NA · completed
- NCT06490900 — Influence of Intermittent Hypoxia on Glycemic Control · NA · completed
- NCT04472442 — Intermittent Hypoxia Paired with High Intensity Training in Brain Injury · NA · completed
- NCT05898685 — Effect of a Single Session of Intermittent Hypoxia on Hematological Variables · NA · completed
Other University of Texas at Austin trials
Trials by the same sponsor.
- NCT07319234 — Development of MENU Protocol · NA · not yet recruiting
- NCT07480109 — Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) · NA · not yet recruiting
- NCT07069413 — Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children · NA · not yet recruiting
- NCT07370311 — A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisi · NA · not yet recruiting
- NCT07441122 — Enhancing Attention in Elderly Using a Brain-Computer-Interface · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05423470 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Texas at Austin
- Last refreshed: 7 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05423470.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing